ARKK vs IBB
ARK Innovation ETF vs iShares Biotechnology ETF
ARKK$81.53
ARK Innovation ETF
Active disruptive-innovation strategy.
Expense: 0.75%Yield: 0.00%
IBB$197.34
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: 0.44%Yield: 0.22%
Quick take
- • IBB has the lower expense ratio at 0.44% vs 0.75% for ARKK.
- • IBB pays a higher dividend yield (0.22%).
Side-by-side metrics
| Metric | ARKK | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $6.53B | $9.09B |
YTD return | 4.21% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.46 | 0.69 |
P/E ratio | 48.06 | 24.89 |
Last price | $81.53 | $197.34 |
Inception | — | — |
Issuer | ARK | iShares |
ARKK top holdings
Top holdings · ARKK
| TSLA | Tesla Inc | 10.19% |
| TEM | Tempus AI Inc Class A common stock | 5.58% |
| AMD | Advanced Micro Devices Inc | 4.98% |
| CRSP | CRISPR Therapeutics AG | 4.87% |
| HOOD | Robinhood Markets Inc Class A | 4.49% |
| SPCX | Space Exploration Technologies Corp Class A | 4.48% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 4.18% |
| TWST | Twist Bioscience Corp | 3.95% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 3.53% |
| BEAM | Beam Therapeutics Inc | 3.31% |
Sector breakdown · ARKK
Consumer Cyclical13.0%
Technology25.8%
Communication Services7.1%
Financial Services12.8%
Industrials9.3%
Healthcare32.0%
IBB top holdings
Top holdings · IBB
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
Sector breakdown · IBB
Healthcare100.0%
About ARKK
ARKK (ARK Innovation ETF) is Active disruptive-innovation strategy. Managed by ARK, the fund carries $6.5B in assets under management, an expense ratio of 0.75%. Its largest holding is Tesla Inc (TSLA), which represents 10.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 13.0%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.